Combined effect of hydroxypropyl methylcellulose and hydroxypropyl-β- cyclodextrin on physicochemical and dissolution properties of celecoxib

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 59, Issue 3-4, 2007, Pages 237-244

  Cappello, Brunella ^a   Di Maio, Clelia ^a   Iervolino, Maria ^a   Miro, Agnese ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Celecoxib; Dissolution; Hydroxypropyl methylcellulose; Hydroxypropyl cyclodextrin; Inclusion complex; NMR; Ternary systems

Indexed keywords

EID: 36049029975     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-007-9319-y     Document Type: Article

References (25)

1. Simon, L.S., Weaver, A.L., Graham, D.Y., Kivitz, A.J., Lipsky, P.E., Hubbard, R.C., Isakson, P.C., Verburg, K.M., Yu, S.S., Zhao, W.W., Geis, S.G.: Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomised controlled trial. J. Am. Med. Assoc. 282, 1961-1963 (1999)
2. Silverstein, F.E., Faich, G., Goldstein, J.L., Simon, L., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N.M., Stenson, W., Burr, A.M., Zhao, W.W., Kent, J.D., Lefkowith, J.B., Verburg, K.M., Geis, S.: Gastrointestinal toxicity with celecoxib versus nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study, a randomized controlled trial. J. Am. Med. Assoc. 284, 1247-1255 (2000)
3. White, W.B., Faich, G., Borer, J.S., Makuch, R.W.: Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. Am. J. Cardiol. 92, 411-418 (2003)
4. Isakson P., Zweifel B., Masferrer J., Koboldt C., Seibert K., Hubbard R., Geis S., Needleman, P.: Specific COX-2 inhibitors: from bend to beside. In: Vane, J., Botting, J. (eds.) Selective Cox-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential, pp. 127-133. Kluwer Academic Publishers, London (1998)
5. Paulson, S.K., Vaughn, M.B., Jessen, S.M., Lawal, Y., Gresk, C.J., Yan, B., Maziasz, J., Cook, C.S., Karim, A.: Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J. Pharmacol. Exp. Ther. 297, 638-645 (2001)
6. Shina, V.R., Anitha, R., Ghosh, S., Nanda, A., Kumria, R.: Complexation of celecoxib with β-cyclodextrin: characterization of the interaction in solution and in solid state. J. Pharm. Sci. 94, 676-687 (2005)
7. Reddy, M.N., Rehana, T.S., Ramakrishna, S., Chowdary, K.P.R., Diwan, P.D.: β-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies. AAPS pharm. Sci. http//www. aaapspharmsci.org 6 Article 7 (2004)
8. Nagarsenker, M.S., Joshi, M.S.: Celecoxib-cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage. Drug. Dev. Ind. Pharm, 31, 169-178 (2005)
9. Ventura, C.A., Tommasini, S., Falcone, A., Giannone, I., Paolino, A., Sdrafkakis, V., Mondello, M.R., Pugliesi, G.: Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin. Int. J. Pharm. 314, 37-45 (2006)
10. Loftsson, T., Fridriksdöttir H., Sigurdardöttir A.M., Ueda, H.: The effect of water-soluble polymers on drug-cyclodextrin complexation. Int. J. Pharm. 110, 169-177 (1994)
11. Loftsson, T., Järvinen T.: Cyclodextrins in ophthalmic drug delivery. Adv. Drug. Deliv. Rev. 36, 59-79 (1999)
12. Cappello, B., Carmignani, C., Iervolino, M., La Rotonda, M.I., Saettone, M.F.: Solubilization of tropicamide by hydroxypropyl-β-cyclodextrin and water-soluble polymers: in vitro/in vivo studies. Int. J. Pharm. 213, 75-81 (2001)
13. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965)
14. Inoue, Y.: NMR studies of the structural and properties of cyclodextrins and their inclusion complexes. Ann. R. NMR S. 27, 59-101 (1993)
15. 13C NMR study on diclofenac/β-cyclodextrin and diclofenac/2-hydroxypropyl-β- cyclodextrin systems. J. Chem. Res., Synop. 414, 1761-1795 (1999)
16. Zhao, D., Liao, K., Ma, X., Yan, X.: Study of the supermolecular inclusion of β-cyclodextrin with andrographolide. J. Incl. Phenom. 43, 259-264 (2002)
17. Redenti, E., Pasini, M., Ventura, P., Spisni, A., Vikman, M., Szejtli, J.: The terfenadine/β-cyclodextrin inclusion complex. J. Incl. Phenom. 15, 281-292 (1993)
18. Ribeiro, L., Loftsson, T., Ferreira, D., Veiga, F.: Investigation and physiochemical characterization of vinopectine-solfobutyl ether β-cyclodextrin binary and ternary complexes. Chem. Pharm. Bull. 51, 914-922 (2003)
19. Loftsson, T.: U.S. Patent 5472954, Iceland, Cyclops h.f. (1995)
20. Liu, C., Desai, K.G.H., Liu, C.: Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug, Dev. Ind. Pharm. 31, 1-10 (2005)
21. Kurazumi, M., Nambu, N., Nagai, T.: Inclusion compounds of non-steroidal anti-inflammatory and other slightly water-soluble drugs with α- and β-cyclodextrins in powdered form. Chem. Pharm. Bull. 23, 3062-3068 (1975)
22. Ventura, C.A., Tirendi, S., Puglisi, G., Bousquet, E., Panza, L.: Improvement of water solubility and dissolution rate of ursodeoxycholic acid and chenodeoxycholic acid by complexation with natural and modified β-cyclodextrins. Int. J. Pharm. 149, 1-13 (1997)
23. Paradkar, A.R., Chauhan, B., Yamamura, S., Pawar, A.P.: Preparation and characterization of glassy celecoxib. Drug Dev. Ind. Pharm. 29, 739-744 (2003)
24. Corrigan, O.I., Stanley, T.: Mechanism of drug dissolution rate enhancement from β-cyclodextrin-drug systems. J. Pharm. Pharmacol. 34, 621-626 (1982)
25. Mura, P., Faucci, M.T., Bettinetti, G.P.: The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl- β-cyclodextrin. Eur. J. Pharm. Sci. 13, 187-194 (2001)